ArticleMaterials today. Bio2025
Long-term SiNPs exposure induced genetic instability and malignant transformation via SQSTM1/p62-mediated autophagy dysfunction in lungs.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As one of the most widely used nanomaterials, silica nanoparticles (SiNPs) have raised significant concerns regarding their toxicity, while their potential carcinogenicity remains poorly understood. During occupational exposure, SiNPs primarily enter the human body through the respiratory tract, thus we aimed to investigate the SiNPs-induced malignant transformation and correlated mechanisms in lungs. Fischer 344 rats underwent weekly intratracheal instillation of SiNPs for six months, followed by an additional six-month observation period to evaluate long-term effects. Results demonstrated the development of precancerous lesions in lungs of rats, which were associated with increased pulmonary glucose metabolism, chronic inflammation, squamous metaplasia, and epithelial-mesenchymal transition (EMT). Similarly, BEAS-2B cells exposed to SiNPs over 40 passages exhibited enhanced abilities in proliferation, migration, invasion, and anchorage-independent colony formation. In addition, genotoxicity was observed in BEAS-2B cells, including increased micronucleus formation, aberrant cell division, and elevated chromosomal aberration frequency. Mechanistically, SiNPs activated SQSTM1/p62-mediated autophagy dysfunction, which in turn induced mitotic catastrophe by interfering with the MDM2/p53/Aurora B signaling pathway. Concurrently, SQSTM1/p62 accumulation suppressed DNA damage repair by enhancing its interaction with RNF168. Molecular docking simulation further predicted that SiNPs directly bind to SQSTM1/p62 through electrostatic interactions, inducing conformational changes in SQSTM1/p62. Notably, SQSTM1/p62-knockout significantly attenuated SiNPs-induced DNA damage and malignant transformation , and modulated the expression of Aurora B and RNF168 signaling pathways. These findings demonstrated the critical role of SQSTM1/p62-mediated autophagy dysfunction in SiNPs-induced genotoxicity and malignant transformation in lungs, offering novel insights into SiNPs-related carcinogenicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.